A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
Georgetown University
Study ID
NCT04675476
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 80 Years
Healthy Volunteers
Accepted

Interventions

  • Provider Prompt & Patient Outreach and Education — BEHAVIORAL
    To target lack of provider-prompted discussion about lung screening, an electronic medical record (EMR) message will be sent to primary care providers prior to scheduled visits with screening-eligible patients to notify them of the patient's eligibility and to encourage discussion of the benefits and limitations of the test. To target patient-level knowledge about lung screening, an outreach specialist will educate screening-eligible patients about the benefits and limitations of the test prior to their visit.

Study Details

To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.

Key Dates

Start date
Mar 11, 2024
Status verified
Dec 2024
Primary completion
Dec 31, 2025
Completion
Feb 28, 2026

Study Design

Enrollment
368 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING

Arms

  • Experimental: Multilevel Intervention
  • No Intervention: Nonequivalent Control Group

Primary Outcome Measure

provider-patient discussion [ Time Frame: 1-week post-visit ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MedStar HealthWashington D.C.District of Columbia20007
Andrew Canning

Find similar trials in Washington D.C., DC

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
MedStar Health· Washington D.C., DC

Related Studies